RE-BVS – Piemonte Repository

Sfoglia per AUTORE
PRATI V
Collezione ASL Asti

Items : 6

TEAM Study: Upfront Docetaxel Treatment in Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Real-World, Multicenter, Retrospective Analysis. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2024 Apr;22(2):56-67.e16. doi: 10.1016/j.clgc.2023.08.006. Epub 2023 Sep 7.

2024
ASL Cuneo 2
ASL Asti
ASL Città di Torino
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Tucci M; Gennari A; Maio MD; Buttigliero C; Ortega C; Rossi M; Vellani G; Airoldi M; Vormola R; Numico G; Depetris I; Comandone A; Buosi R; Stevani I; Guglielmini P; Icardi M; Dionisio R; Cattrini C; Vignani F; Brusa F; Prati V; Ruatta F; Filippi R; Mennitto A; Vana F; Fea E; Vanella P; Pisano C; Turco F; et alii...

MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma. in Journal of clinical pathology / J Clin Pathol. 2022 Jan;75(1):39-44. doi: 10.1136/jclinpath-2020-207089. Epub 2020 Nov 3.

2022
ASL Asti

Brunelli M; Tafuri A; Cima L; Cerruto MA; Milella M; Zivi A; Buti S; Bersanelli M; Fornarini G; Vellone VG; Rebuzzi SE; Procopio G; Verzoni E; Bracarda S; Sabbatini R; Baldessari C; Eccher A; Passalacqua R; Perrucci B; Giganti MO; Donini M; Panni S; Tucci M; Prati V; Ortega C; Caliò A; Alongi F; Munari E; Pappagallo G; et alii...

Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study. in Journal of personalized medicine / J Pers Med. 2022 Apr 30;12(5):727. doi: 10.3390/jpm12050727.

2022
ASL Asti
AOU Novara

Fassan M; Sbaraglia M; Galuppini F; Aberasturi Plata Y; Zito-Marino F; Franco R; Rizzo M; Massari F; Cossarizza A; Bollito E; Salvioni R; Conti G; Lapini A; Colombo P; Patriarca C; Pierconti F; Basso U; Maruzzo M; Munari E; Atzori F; Montagnani I; Gobbo S; Umari P; Mosca A; Iacovelli R; Pappagallo G; Alongi F; Eccher A; Ortega C; et alii...

Maintenance versus discontinuation of androgen deprivation therapy during continuous or intermittent docetaxel administration in castration-resistant prostate cancer patients: A multicentre, randomised Phase III study by the Piemonte Oncology Network. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 Sep;155:127-135. doi: 10.1016/j.ejca.2021.06.034. Epub 2021 Aug 6.

2021
ASL Asti
AO Cuneo
ASL Città di Torino
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
ASL Biella

Berruti A; Tucci M; Gennari A; Baier S; Bellissimo AR; Ciccone G; Montagnani F; Comandone A; Chiappino I; Dal Canton O; Masini C; Sacco C; Zamparini M; Sirotova Z; Fea E; Valcamonico F; Vanella P; Ortega C; Buttigliero C; Prati V; Bianchi S; Mosca A; Dalla Volta A; Amoroso D;

Maintenance versus discontinuation of androgen deprivation therapy during docetaxel administration with a continuous or an intermittent schedule in metastatic, castration resistant, prostate cancer patients. A multicenter randomized phase III study of the piemonte oncology network in Tumori

2020
ASL Torino 4
ASL Asti
ASL Biella
ASL Vercelli

Bianchi S; Alessandra M; Prati V; Ortega C; Buttigliero C; Fea E; Vanella P; Valcamonico F; Ciccone G; Sirotova Z; Chiappino I; Dal Canton O; Masini C; Saccot C; Amoroso D; Leone F; Comandone A; Gennari A; Berruti A; Tucci M;

Maintenance versus discontinuation of androgen deprivation therapy during docetaxel administration with a continuous or an intermittent schedule in metastatic, castration resistant, prostate cancer patients: A multicenter randomized phase III study of the Piemonte Oncology Network in Annals of Oncology

2020
ASL Asti
ASL Biella

Berruti A; Mosca A; Bianchi S; Prati V; Ortega C; Buttigliero C; Fea E; Vanella P; Valcamonico F; Ciccone G; Sirotova Z; Chiappino I; Canton OD; Masini C; Sacco† C; Amoroso D; Montagnani F; Comandone A; Gennari A; Tucci M;